694 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Teva Investors Get Headache Relief https://www.wsj.com/articles/teva-investors-get-headache-relief-1537200489?mod=rss_Technology Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
GW Pharmaceuticals Up on Encouraging Schizophrenia Data http://www.zacks.com/stock/news/190320/gw-pharmaceuticals-up-on-encouraging-schizophrenia-data?cid=CS-ZC-FT-190320 Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
Earnings Growth Accelerates in Q1 http://www.zacks.com/commentary/111002/earnings-growth-accelerates-in-q1?cid=CS-ZC--111002 Apr 21, 2017 - Earnings Growth Accelerates in Q1
Stocks making the biggest moves premarket: MMM, UTX, VZ, LLY & more https://www.cnbc.com/2018/07/24/stocks-making-the-biggest-moves-premarket-mmm-utx-vz-lly--more.html Jul 24, 2018 - Names on the move ahead of the open.
Earnings Growth Returns, Will it Continue? http://www.zacks.com/commentary/102303/earnings-growth-returns-will-it-continue?cid=CS-ZC--102303 Jan 27, 2017 - Earnings Growth Returns, Will it Continue?
Why Alder Biopharma Stock Is Crashing Today https://www.fool.com/investing/2017/06/27/why-alder-biopharma-stock-is-crashing-today.aspx?source=iedfolrf0000001 Jun 27, 2017 - Disappointing phase 3 trial results are increasing concerns that its migraine drug might not be a commercial success.
Why Snyder's-Lance, Incyte, and Tenet Healthcare Slumped Today https://www.fool.com/investing/2017/04/17/why-snyders-lance-incyte-and-tenet-healthcare-slum.aspx?source=iedfolrf0000001 Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
What Happened in the Stock Market Today https://www.fool.com/investing/2017/04/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001 Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
Big Pharma Diabetes Drugs Not So Sweet. What's in Store? http://www.zacks.com/stock/news/262544/big-pharma-diabetes-drugs-not-so-sweet-whats-in-store?cid=CS-ZC-FT-262544 May 31, 2017 - Aales of diabetes drugs from most large pharma companies slipped in the first quarter.
The Key Reason Incyte Corporation Added $850 Million in Market Cap in August https://www.fool.com/investing/2017/09/05/the-key-reason-incyte-corporation-added-850-millio.aspx?source=iedfolrf0000001 Sep 05, 2017 - An update on bariticinib's review timeline has Wall Street rightly excited.

Pages: 12345678...70

<<<Page 3>